Premium
ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR DETERMINATION OF IgG ANTIBODIES TO HUMAN CYTOMEGALOVIRUS
Author(s) -
Sarov Israel,
Andersen Paul,
Andersen Hans Kerzel
Publication year - 1980
Publication title -
acta pathologica microbiologica scandinavica section b microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0304-131X
DOI - 10.1111/j.1699-0463.1980.tb02597.x
Subject(s) - antigen , complement fixation test , antibody , serology , virology , cytomegalovirus , chemistry , population , microbiology and biotechnology , enzyme , seroconversion , human cytomegalovirus , epitope , biology , virus , immunology , herpesviridae , medicine , viral disease , biochemistry , environmental health
A solid‐phase enzyme linked immunosorbent assay (ELISA) for determination of IgG antibodies to cytomegalovirus (CMV) is described. The assay uses purified CMV and extracts of CMV infected cells as antigen. Antigens were desiccated onto the bottom surface of polystyrene microcuvettes. The antibodies bound to the antigens were assayed by anti‐IgG‐alkaline phosphate conjugate followed by addition of the enzyme substrate. Titration curves have been obtained from the sera of 35 blood donors and of 23 patients. Comparison of results obtained by ELISA with those obtained by complement fixation (CF) shows that there is agreement between the tests. Both purified CMV and extracts of CMV infected cells were found to be suitable antigens. Purified CMV was of value particularly in those sera which show high reactivity against control antigen. The ELISA technique described is approximately 412 to 548 times more sensitive than the CF test when purified CMV or extracts of CMV infected cells, respectively, are used as antigens. No significant heterotypic rise to CMV was observed by ELISA in three sets of sera with seroconversion to herpes simplex virus. The ELISA technique gives objective results, is easily performed, and may be adaptable as a routine test both for serological diagnosis of CMV infection and for screening of the general population.